9Bio Therapeutics
PrivateLast Round
Accelerator
Jun 23, 2025
Total Funding Raised
$429,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
9Bio Therapeutics operates in Healthcare & Life Sciences and is based in Québec, Quebec. Its latest recorded funding round was an Accelerator round in June 2025.
9Bio Therapeutics is a biotechnology company that develops oncology therapeutics using its AI-guided structural biology platform to design drugs that selectively target tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
9Bio Therapeutics Comparables
Compare 9Bio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bonum Therapeutics | 82% | |
| BioAtla | 73% | |
| Tentarix | 71% |
For institutional investors. Book with your work email.
9Bio Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 23, 2025 | ||||
| Grant | Mar 20, 2025 | ||||
| Accelerator | May 21, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
9Bio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Accelerator |
| Merck Digital Sciences Studio | Accelerator |
| Natural Sciences and Engineering Research Council of Canada | Grant |
| adMare BioInnovations | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 3033% MoM, reaching 2.2K.
- Jan 2, 2026
Monthly visitors increased 154% MoM.
For institutional investors. Book with your work email.
9Bio Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 9Bio Therapeutics's valuation, stock price, and market status.
Is 9Bio Therapeutics a public or private company?
9Bio Therapeutics is a private company.
What is the current stock price of 9Bio Therapeutics?
9Bio Therapeutics is a private company, so its shares have no public market price. Caplight tracks 9Bio Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 9Bio Therapeutics worth (valuation)?
Valuation information for 9Bio Therapeutics is not publicly available.
Can I buy 9Bio Therapeutics stock?
9Bio Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 9Bio Therapeutics's last funding round?
9Bio Therapeutics's most recent funding round was Accelerator on June 23, 2025.
Who are the main investors in 9Bio Therapeutics?
Key investors in 9Bio Therapeutics include Consortium Québécois sur la découverte du médicament, Merck Digital Sciences Studio, adMare BioInnovations.
Will 9Bio Therapeutics IPO soon?
No public IPO plans have been announced for 9Bio Therapeutics.
How can I track 9Bio Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in 9Bio Therapeutics's shares on secondary markets.